Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe

J. E. Swartz; L. Vandekerckhove; H. Ammerlaan; A. C. De Vries; J. Begovac; W. F.W. Bierman; C. A.B. Boucher; M. E. Van Der Ende; Z. Grossman; R. Kaiser; I. Levy; T. Mudrikova; R. Paredes; D. Perez-Bercoff; M. Pronk; C. Richter; J. C. Schmit; J. Vercauteren; M. Zazzi; S. Židovec Lepej; Andrea De Luca; A. M.J. Wensing

doi:10.1093/jac/dkv033

Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe

J. E. Swartz, L. Vandekerckhove, H. Ammerlaan, A. C. De Vries, J. Begovac, W. F.W. Bierman, C. A.B. Boucher, M. E. Van Der Ende, Z. Grossman, R. Kaiser, I. Levy, T. Mudrikova, R. Paredes, D. Perez-Bercoff, M. Pronk, C. Richter, J. C. Schmit, J. Vercauteren, M. Zazzi, S. Židovec LepejAndrea De Luca, A. M.J. Wensing

Università Cattolica del Sacro Cuore

Research output: Contribution to journal › Article

9 Citations (Scopus)

Abstract

The combination of tenofovir and efavirenz with either lamivudine or emtricitabine (TELE) has proved to be highly effective in clinical trials for first-line treatment of HIV-1 infection. However, limited data are available on its efficacy in routine clinical practice.

Original language	English
Pages (from-to)	1850-1857
Number of pages	8
Journal	Journal of Antimicrobial Chemotherapy
Volume	70
DOIs	https://doi.org/10.1093/jac/dkv033
Publication status	Published - 2015

Keywords

HIV-1
co-formulation
first-line antiretroviral therapy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/jac/dkv033

Cite this

Swartz, J. E., Vandekerckhove, L., Ammerlaan, H., De Vries, A. C., Begovac, J., Bierman, W. F. W., Boucher, C. A. B., Van Der Ende, M. E., Grossman, Z., Kaiser, R., Levy, I., Mudrikova, T., Paredes, R., Perez-Bercoff, D., Pronk, M., Richter, C., Schmit, J. C., Vercauteren, J., Zazzi, M., ... Wensing, A. M. J. (2015). Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe. Journal of Antimicrobial Chemotherapy, 70, 1850-1857. https://doi.org/10.1093/jac/dkv033

@article{098b660ce01345ca81d8043f13fcf603,

title = "Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe",

abstract = "The combination of tenofovir and efavirenz with either lamivudine or emtricitabine (TELE) has proved to be highly effective in clinical trials for first-line treatment of HIV-1 infection. However, limited data are available on its efficacy in routine clinical practice.",

keywords = "HIV-1, co-formulation, first-line antiretroviral therapy, HIV-1, co-formulation, first-line antiretroviral therapy",

author = "Swartz, {J. E.} and L. Vandekerckhove and H. Ammerlaan and {De Vries}, {A. C.} and J. Begovac and Bierman, {W. F.W.} and Boucher, {C. A.B.} and {Van Der Ende}, {M. E.} and Z. Grossman and R. Kaiser and I. Levy and T. Mudrikova and R. Paredes and D. Perez-Bercoff and M. Pronk and C. Richter and Schmit, {J. C.} and J. Vercauteren and M. Zazzi and {{\v Z}idovec Lepej}, S. and {De Luca}, Andrea and Wensing, {A. M.J.}",

year = "2015",

doi = "10.1093/jac/dkv033",

language = "English",

volume = "70",

pages = "1850--1857",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

}

Swartz, JE, Vandekerckhove, L, Ammerlaan, H, De Vries, AC, Begovac, J, Bierman, WFW, Boucher, CAB, Van Der Ende, ME, Grossman, Z, Kaiser, R, Levy, I, Mudrikova, T, Paredes, R, Perez-Bercoff, D, Pronk, M, Richter, C, Schmit, JC, Vercauteren, J, Zazzi, M, Židovec Lepej, S, De Luca, A & Wensing, AMJ 2015, 'Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe', Journal of Antimicrobial Chemotherapy, vol. 70, pp. 1850-1857. https://doi.org/10.1093/jac/dkv033

TY - JOUR

T1 - Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe

AU - Swartz, J. E.

AU - Vandekerckhove, L.

AU - Ammerlaan, H.

AU - De Vries, A. C.

AU - Begovac, J.

AU - Bierman, W. F.W.

AU - Boucher, C. A.B.

AU - Van Der Ende, M. E.

AU - Grossman, Z.

AU - Kaiser, R.

AU - Levy, I.

AU - Mudrikova, T.

AU - Paredes, R.

AU - Perez-Bercoff, D.

AU - Pronk, M.

AU - Richter, C.

AU - Schmit, J. C.

AU - Vercauteren, J.

AU - Zazzi, M.

AU - Židovec Lepej, S.

AU - De Luca, Andrea

AU - Wensing, A. M.J.

PY - 2015

Y1 - 2015

N2 - The combination of tenofovir and efavirenz with either lamivudine or emtricitabine (TELE) has proved to be highly effective in clinical trials for first-line treatment of HIV-1 infection. However, limited data are available on its efficacy in routine clinical practice.

AB - The combination of tenofovir and efavirenz with either lamivudine or emtricitabine (TELE) has proved to be highly effective in clinical trials for first-line treatment of HIV-1 infection. However, limited data are available on its efficacy in routine clinical practice.

KW - HIV-1

KW - co-formulation

KW - first-line antiretroviral therapy

KW - HIV-1

KW - co-formulation

KW - first-line antiretroviral therapy

UR - http://hdl.handle.net/10807/68433

U2 - 10.1093/jac/dkv033

DO - 10.1093/jac/dkv033

M3 - Article

SN - 0305-7453

VL - 70

SP - 1850

EP - 1857

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

ER -

Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this